(1S,3S,5S)-2-[(2S)-2-amino-2-[(5R)-3-hydroxy-1-adamantyl]acetyl]-2-azabicyclo[3.1.0]hexane-3-carbonitrile
was used by NIH 3D workflows to automatically generate models for
James Tyrwhitt Drake
Created:
8/4/15
Submitted:
3/6/23
Published:
3/6/23
Select an image below to view
Category
Description
Saxagliptin (rINN) is an orally active hypoglycemic (anti-diabetic drug) of the new dipeptidyl peptidase-4 (DPP-4) inhibitor class of drugs. FDA approved on July 31, 2009.
